Mesenchymal stem cells (MSCs) have attracted much attention in regenerative medicine and tissue engineering due to their pluripotency, self-renewal ability and low immunogenicity.

The Japanese government has included some reviewed regenerative medical products in medical insurance reimbursement.

In recent years, in addition to the mainland of China, Hong Kong, Macao, Taiwan and other places in my country have also joined the regenerative medicine research and development army!

Recently, Chinese researchers have used a new type of stem cell therapy, namely olfactory mucosal mesenchymal stem cells (hOM-MSC), to treat 5 patients with Parkinson's disease, and have achieved amazing results.

Advances in stem cell therapy offer new hope for the treatment of multiple systems and chronic diseases.

Dental pulp stem cells are expected to become the "terminator" of osteoarthritis.

Recently, Shanghai plans to set up three industrial pilot funds with a total scale of 89 billion yuan.

Stem cells are a type of cells that have the potential to self-renew and differentiate.